https://healthheraldgrenada.com/article/916222271-momcozy-launches-plus-baby-wipes-built-for-every-messy-milestone-99-purified-water-8-8-independently-certified-by-intertek Health Herald Grenada en PressRelease 2026-05-30T13:00:00+00:00 Momcozy Launches Plus Baby Wipes Built for Every “Messy Milestone”: 99% Purified Water, 8″ × 8″, Independently Certified by Intertek https://ml.globenewswire.com/Resource/Download/ebfb55bc-4302-46b9-836d-07065b2dc26d/momcozy-27b.jpg https://healthheraldgrenada.com/article/916210640-immatics-presents-clinical-activity-of-ima203cd8-prame-cell-therapy-in-hard-to-treat-gynecologic-cancers-at-2026-asco-annual-meeting Health Herald Grenada en PressRelease 2026-05-30T12:00:00+00:00 Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png https://healthheraldgrenada.com/article/916210703-cogent-biosciences-announces-detailed-clinical-data-from-peak-phase-3-trial-with-bezuclastinib-in-combination-with-sunitinib-in-gastrointestinal Health Herald Grenada en PressRelease 2026-05-30T12:00:00+00:00 Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/0bd526c3-2e64-4b0d-8de9-f7c2d662cb4c/medium/results-of-genotype-subgroup-analysis.png https://healthheraldgrenada.com/article/916210711-atlanta-based-health-center-celebrates-50-years-of-service Health Herald Grenada en PressRelease 2026-05-30T12:00:00+00:00 Atlanta Based Health Center celebrates 50 Years of Service https://ml.globenewswire.com/media/YWYzM2I1NmUtYmI2OC00M2YzLTlmNzEtNzhkY2EzYmZkY2VmLTEyMjA4MDgtMjAyNi0wNS0zMC1lbg==/tiny/The-Family-Health-Centers-of-G.png https://healthheraldgrenada.com/article/916210716-replimune-presents-3-year-landmark-overall-survival-analysis-from-ignyte-clinical-trial-during-oral-presentation-at-the-2026-american-society-of Health Herald Grenada en PressRelease 2026-05-30T12:00:00+00:00 Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting https://ml.globenewswire.com/media/YjE1MDE2MDctNGExMy00NmY3LWFkZjEtNjAyNTlhZDQ5MDMxLTExMjIxMDEtMjAyNi0wNS0zMC1lbg==/tiny/Replimune-Inc-.png https://healthheraldgrenada.com/article/916198909-how-riccio-pharmacy-makes-online-medicine-delivery-easier-for-patients Health Herald Grenada en PressRelease 2026-05-30T10:00:01+00:00 How Riccio Pharmacy Makes Online Medicine Delivery Easier For Patients? https://ml.globenewswire.com/Resource/Download/eeffad72-6b60-45dd-8de4-6cd62e5bcbaa/image1.png https://healthheraldgrenada.com/article/916165372-mikey-moran-launches-glzd-combining-skincare-and-fragrance-into-men-s-grooming-routine Health Herald Grenada en PressRelease 2026-05-30T06:09:36+00:00 Mikey Moran Launches GLZD, Combining Skincare and Fragrance Into Men’s Grooming Routine https://ml.globenewswire.com/Resource/Download/625a77d4-a415-468e-8f3a-bfbda2220861/gldz1.jpg https://healthheraldgrenada.com/article/916152356-national-nursing-organizations-file-nurse-forward-lawsuit-against-the-department-of-education-over-professional-degree-designation Health Herald Grenada en PressRelease 2026-05-30T04:05:00+00:00 National Nursing Organizations File Nurse-Forward Lawsuit Against the Department of Education Over Professional Degree Designation https://ml.globenewswire.com/media/YmJlYjVjMjMtOTMzNi00NWMzLWIxMDUtY2Y4OGUwNzY3ZDgyLTUwMDE2MTk2Mi0yMDI2LTA1LTMwLWVu/tiny/American-Nurses-Enterprise.png https://healthheraldgrenada.com/article/916136814-bioma-probiotics-claims-evaluated-what-the-2026-gut-health-research-reveals-about-this-seed-probiotics-alternative-its-ingredients-weight-loss Health Herald Grenada en PressRelease 2026-05-30T02:08:28+00:00 Bioma Probiotics Claims Evaluated: What the 2026 Gut Health Research Reveals About This Seed Probiotics Alternative, Its Ingredients, Weight Loss Support, and Consumer Reviews https://ml.globenewswire.com/Resource/Download/a4bef706-0f29-4401-aee6-fcd9856f7fc1/2.png https://healthheraldgrenada.com/article/916086737-national-nursing-organizations-file-nurse-forward-lawsuit-against-the-department-of-education-over-professional-degree-designation Health Herald Grenada en PressRelease 2026-05-29T22:15:39+00:00 National Nursing Organizations File Nurse-Forward Lawsuit Against the Department of Education Over Professional Degree Designation https://ml.globenewswire.com/media/YTJiMjc1NWMtYjUyMy00NTMxLWJjYzUtY2E3OThkZjVlYzA3LTUwMDE2MTk2Mi0yMDI2LTA1LTI5LWVu/tiny/American-Nurses-Enterprise.png https://healthheraldgrenada.com/article/916086704-renown-jazz-artists-hit-the-stage-to-help-georgians-receive-healthcare Health Herald Grenada en PressRelease 2026-05-29T21:23:58+00:00 Renown Jazz Artists Hit the Stage to Help Georgians Receive Healthcare https://ml.globenewswire.com/media/MWVhN2Q1NDctYzg4ZS00ZjkxLWFhMGQtYjcyYjA4ZjlkOGJjLTEyMjA4MDgtMjAyNi0wNS0yOS1lbg==/tiny/The-Family-Health-Centers-of-G.png https://healthheraldgrenada.com/article/916068921-celularity-receives-nasdaq-notice-regarding-form-10-q Health Herald Grenada en PressRelease 2026-05-29T21:15:00+00:00 Celularity Receives Nasdaq Notice Regarding Form 10-Q https://ml.globenewswire.com/media/ZGUzZjA0MjktZjQ4Zi00Yzk0LTllODYtMmU2MTQ5NWIxOTBjLTEyMTY1NjItMjAyNi0wNS0yOS1lbg==/tiny/Celularity-Inc-.png https://healthheraldgrenada.com/article/916068876-kane-biotech-announces-grant-of-stock-options Health Herald Grenada en PressRelease 2026-05-29T21:05:00+00:00 Kane Biotech Announces Grant of Stock Options https://ml.globenewswire.com/media/a2ad1d52-1d5a-425c-93de-45cc52c3784b/small/kane-logo-cropped-transbg-png.png https://healthheraldgrenada.com/article/916068935-quest-pharmatech-provides-corporate-update-including-voluntary-adoption-of-csa-blanket-order-51-93-to-file-financial-statements-and-md-a-on Health Herald Grenada en PressRelease 2026-05-29T21:00:00+00:00 Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis https://ml.globenewswire.com/media/fd192331-1a31-44aa-b520-5409d720a0b6/small/questpt-logo-jpg.jpg https://healthheraldgrenada.com/article/916068894-zevra-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Herald Grenada en PressRelease 2026-05-29T20:30:00+00:00 Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://healthheraldgrenada.com/article/916068932-crescent-biopharma-announces-grants-of-inducement-awards Health Herald Grenada en PressRelease 2026-05-29T20:15:00+00:00 Crescent Biopharma Announces Grants of Inducement Awards https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://healthheraldgrenada.com/article/916068942-jade-biosciences-to-host-conference-call-and-webcast-on-june-1-2026-at-8-00-a-m-et-to-discuss-interim-phase-1-healthy-volunteer-results-for Health Herald Grenada en PressRelease 2026-05-29T20:05:00+00:00 Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://healthheraldgrenada.com/article/916068817-kiniksa-pharmaceuticals-to-present-at-upcoming-investor-conferences Health Herald Grenada en PressRelease 2026-05-29T20:01:00+00:00 Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences https://ml-eu.globenewswire.com/media/84055882-69ed-48db-be7d-99cc55be5ff3/small/image1-jpg.jpg https://healthheraldgrenada.com/article/916068913-arvinas-to-present-at-jefferies-global-healthcare-conference Health Herald Grenada en PressRelease 2026-05-29T20:01:00+00:00 Arvinas to Present at Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/563780a0-f8d9-4e37-8665-b622ef2caa5b/small/arvinas-logoart-lg-jpg.jpg https://healthheraldgrenada.com/article/916068926-xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Herald Grenada en PressRelease 2026-05-29T20:01:00+00:00 Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://healthheraldgrenada.com/article/916068812-transactions-in-zealand-pharma-shares-and-or-related-securities-by-persons-discharging-managerial-responsibilities-and-or-their-closely-associated Health Herald Grenada en PressRelease 2026-05-29T20:00:00+00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://healthheraldgrenada.com/article/916051447-oculis-announces-topline-results-from-diamond-phase-3-trials-with-ocs-01-in-diabetic-macular-edema Health Herald Grenada en PressRelease 2026-05-29T19:05:50+00:00 Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://healthheraldgrenada.com/article/916035295-asap-dental-care-expands-evening-and-weekend-hours-across-greater-jacksonville-to-meet-urgent-dental-and-emergency-needs Health Herald Grenada en PressRelease 2026-05-29T18:01:00+00:00 ASAP Dental Care Expands Evening and Weekend Hours Across Greater Jacksonville to Meet Urgent Dental and Emergency Needs https://pressranger.s3.us-west-1.amazonaws.com/3332063/cfd-back.png https://healthheraldgrenada.com/article/916035423-mannkind-to-host-conference-call-today-to-discuss-afrezza-pediatric-approval Health Herald Grenada en PressRelease 2026-05-29T18:00:00+00:00 MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://healthheraldgrenada.com/article/916035332-fda-issues-draft-guidance-to-cut-unnecessary-animal-testing-for-cancer-drugs Health Herald Grenada en PressRelease 2026-05-29T17:47:00+00:00 FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs https://ml.globenewswire.com/media/YTBlYWFhYzctOTFiOC00NmUxLTkzN2ItNmYzODY4ZDRkZDcyLTUwMDE1NDE1NC0yMDI2LTA1LTI5LWVu/tiny/FDA.png https://healthheraldgrenada.com/article/916020027-kun-peng-international-ltd-announces-1-for-10-reverse-stock-split Health Herald Grenada en PressRelease 2026-05-29T16:54:00+00:00 Kun Peng International Ltd. Announces 1-for-10 Reverse Stock Split https://ml.globenewswire.com/media/5f0ecb01-b884-4500-b97e-41da55af6f14/small/logo-jpg.jpg https://healthheraldgrenada.com/article/916020009-dr-matthew-t-provencher-receives-prestigious-2026-stephen-s-burkhart-shoulder-innovation-research-award Health Herald Grenada en PressRelease 2026-05-29T16:37:46+00:00 Dr. Matthew T. Provencher Receives Prestigious 2026 Stephen S. Burkhart Shoulder Innovation Research Award https://ml.globenewswire.com/media/ZDUzNzA2NjUtZDQzMC00YWEwLWFlMzUtNzU1OWQwMGMzZjkwLTExMzY3NDItMjAyNi0wNS0yOS1lbg==/tiny/The-Steadman-Clinic-and-Steadm.png https://healthheraldgrenada.com/article/916019988-mannkind-announces-fda-approval-of-afrezza-the-first-and-only-inhaled-mealtime-insulin-for-use-in-children-and-adolescents-aged-6-and-older-living Health Herald Grenada en PressRelease 2026-05-29T16:30:00+00:00 MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes https://ml.globenewswire.com/media/f03226ab-008e-469b-b0ef-dea826bb2eab/medium/afrezza-inhaler.png https://healthheraldgrenada.com/article/915987724-the-next-great-ai-revolution-may-be-drug-delivery Health Herald Grenada en PressRelease 2026-05-29T13:05:00+00:00 The Next Great AI Revolution May Be Drug Delivery https://ml.globenewswire.com/media/1f91276c-d820-4666-8efc-2d8786490903/small/neonc-technologies-holding-logo-vector-png.png https://healthheraldgrenada.com/article/915987594-bionexus-gene-lab-corp-calls-for-malaysia-china-biotechnology-cooperation-to-move-beyond-trade-into-co-development Health Herald Grenada en PressRelease 2026-05-29T13:00:00+00:00 BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development https://ml.globenewswire.com/media/92171f6f-2fca-4c7a-b1ac-9bfe6b358e01/medium/sam-tan-chief-executive-officer-of-bionexus-gene-lab-corp-na.jpg https://healthheraldgrenada.com/article/915987647-the-vision-council-foundation-accuweather-and-the-skin-cancer-foundation-unite-for-national-sunglasses-day-2026 Health Herald Grenada en PressRelease 2026-05-29T13:00:00+00:00 The Vision Council Foundation, AccuWeather®, and The Skin Cancer Foundation Unite for National Sunglasses Day 2026 https://ml.globenewswire.com/media/MWI5MDkyMTItZjg4NS00YWQ0LTkwNDQtYzRjOWQ3ODRiZDM4LTUwMDEyNTg4MC0yMDI2LTA1LTI5LWVu/tiny/The-Vision-Council.png https://healthheraldgrenada.com/article/915974298-cannabix-expands-breathlogix-alcohol-screening-technology-into-mining-municipal-and-aviation-sectors-in-australia Health Herald Grenada en PressRelease 2026-05-29T12:45:00+00:00 Cannabix Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in Australia https://ml.globenewswire.com/media/94edf323-c367-4665-b271-4846d02a05ea/medium/cannabix-technologies-inc.Jpg https://healthheraldgrenada.com/article/915974421-srx-health-solutions-invests-in-uber-technologies-inc-and-provides-shareholders-with-portfolio-update Health Herald Grenada en PressRelease 2026-05-29T12:45:00+00:00 SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg https://healthheraldgrenada.com/article/915974533-clearmind-medicine-advances-global-intellectual-property-portfolio-with-japanese-patent-filing-for-innovative-psychedelic-based-depression-treatment Health Herald Grenada en PressRelease 2026-05-29T12:32:00+00:00 Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment https://ml.globenewswire.com/media/bd17cbf4-8124-4f86-8a4c-1fafbb6785af/small/logo-jpg.jpg https://healthheraldgrenada.com/article/915974287-sparrow-pharmaceuticals-to-present-phase-2a-results-for-clofutriben-in-type-2-diabetes-at-the-2026-american-diabetes-association-ada-scientific Health Herald Grenada en PressRelease 2026-05-29T12:30:00+00:00 Sparrow Pharmaceuticals to Present Phase 2a Results for Clofutriben in Type 2 Diabetes at the 2026 American Diabetes Association (ADA) Scientific Session https://ml.globenewswire.com/media/11109705-8086-47a2-af7e-e93ff8d6d5c5/small/sparrow-logo-rgb-2color-horizontal-png.png https://healthheraldgrenada.com/article/915974380-optimi-health-welcomes-expanded-psychedelic-assisted-therapy-access-under-updated-authorized-prescriber-framework-in-australia Health Herald Grenada en PressRelease 2026-05-29T12:30:00+00:00 Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia https://ml.globenewswire.com/media/NDUwMmJkNTYtOTZmMS00ZWJjLTgwZmYtYzhiNWMyMjJmMWM0LTUwMDE2MzM0MC0yMDI2LTA1LTI5LWVu/tiny/OPTIMI-HEALTH-CORP-.png https://healthheraldgrenada.com/article/915974521-imviva-biotech-to-present-data-from-clinical-studies-of-cta313-and-ctd402-validating-its-answer-allogeneic-car-t-platform-in-pediatric-and-adult Health Herald Grenada en PressRelease 2026-05-29T12:30:00+00:00 Imviva Biotech to Present Data from Clinical Studies of CTA313 and CTD402 Validating its ANSWER™ Allogeneic CAR-T Platform in Pediatric and Adult Patient Populations at EULAR and EHA 2026 Congresses https://ml.globenewswire.com/media/YTViODc1NWQtMTY5My00NDhhLThmMzQtZjIxOTM1NGQyY2JlLTEzMTkxMjUtMjAyNi0wNS0yOS1lbg==/tiny/Imviva-US-Holdings-LLC.png https://healthheraldgrenada.com/article/915974539-skyai-appoints-veteran-finance-executive-arthur-levine-as-chief-financial-officer Health Herald Grenada en PressRelease 2026-05-29T12:30:00+00:00 SkyAI Appoints Veteran Finance Executive Arthur Levine as Chief Financial Officer https://ml.globenewswire.com/media/2c710b91-e21d-41a3-8873-c04fa5de00e3/small/skyai-logo-jpg.jpg https://healthheraldgrenada.com/article/915974134-aeon-clinic-redefines-longevity-with-premier-nad-iv-therapy-and-premium-iv-drips-in-dubai Health Herald Grenada en PressRelease 2026-05-29T12:22:22+00:00 AEON Clinic Redefines Longevity with Premier NAD+ IV Therapy and Premium IV Drips in Dubai https://ml-eu.globenewswire.com/media/46867db3-8237-4654-85fb-fdefb258ee6f/medium/aeon-clinic-premier-nad-iv-therapy-and-premium-iv-drips-in-d.jpg https://healthheraldgrenada.com/article/915974251-moleculin-presents-asco-2026-data-demonstrating-no-detectable-cardiotoxicity-with-annamycin-despite-exposure-levels-far-exceeding-conventional Health Herald Grenada en PressRelease 2026-05-29T12:21:00+00:00 Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://healthheraldgrenada.com/article/915974680-bioxytran-highlights-new-book-on-real-time-monitoring-tissue-oxygenation-relevant-to-oxygen-carrier-bxt-25 Health Herald Grenada en PressRelease 2026-05-29T12:03:00+00:00 Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25 https://ml.globenewswire.com/media/383b7569-34f8-4c66-bd5f-996e56457526/small/logo-png.png https://healthheraldgrenada.com/article/915974181-medidata-champions-collaborative-scientific-advancement-at-asco-with-new-research-on-oncology-protocol-optimization-and-car-t-efficacy Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy https://ml.globenewswire.com/media/a26f92c9-b08f-4530-a70f-6dec8dee7e36/small/3ds-medidata-logotype-navy-1-jpg.jpg https://healthheraldgrenada.com/article/915974196-sab-bio-to-present-data-on-sab-142-at-the-american-diabetes-association-s-2026-scientific-sessions-and-focis-2026-annual-meeting Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png https://healthheraldgrenada.com/article/915974227-omniscient-secures-usd-27-2m-series-d-to-accelerate-commercialization-of-ai-enabled-brain-technology Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 Omniscient Secures USD 27.2M Series D to Accelerate Commercialization of AI-Enabled Brain Technology https://ml.globenewswire.com/media/450408c0-3703-414e-84e5-6f4b51be54ac/medium/quicktome-ai-enabled-connectomic-brain-mapping-platform.png https://healthheraldgrenada.com/article/915974354-petmed-express-inc-to-report-fourth-quarter-and-fiscal-year-2026-financial-results-on-tuesday-june-2-2026 Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026 https://ml.globenewswire.com/media/dac159be-c4f9-491f-baa3-811a3ee58631/small/petmeds-pm-green-png.png https://healthheraldgrenada.com/article/915974406-rhythm-pharmaceuticals-announces-seven-abstracts-accepted-for-presentation-at-endo-2026 Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026 https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://healthheraldgrenada.com/article/915974412-tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026 Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 https://ml.globenewswire.com/media/95a7de9f-2b24-4ff3-9b57-f8a35e8c049f/small/tenaya-logo-fullcolor-rgb-jpg.jpg https://healthheraldgrenada.com/article/915974430-tempest-therapeutics-announces-warrant-exercise-for-approximately-2-million-in-gross-proceeds Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://healthheraldgrenada.com/article/915974460-replimune-announces-planned-rp1-bla-resubmission-following-productive-discussion-with-fda Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA https://ml.globenewswire.com/media/YjFjNTVkMTUtYWIxNi00ZmU0LWE0ZTctZTQxMTczNTNhZmFjLTExMjIxMDEtMjAyNi0wNS0yOS1lbg==/tiny/Replimune-Inc-.png https://healthheraldgrenada.com/article/915974530-jyong-biotech-ceo-outlines-fda-pathway-and-global-strategy-in-pharmaboardroom-live-interview Health Herald Grenada en PressRelease 2026-05-29T12:00:00+00:00 Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview https://ml.globenewswire.com/media/a1e08c1c-37e5-4fa0-bc16-0b603810bf0a/small/logo-png.png https://healthheraldgrenada.com/article/915974123-dr-kamalesh-sets-new-benchmarks-for-urological-surgery-in-the-uae-minimally-invasive-maximum-results Health Herald Grenada en PressRelease 2026-05-29T11:58:06+00:00 Dr. Kamalesh Sets New Benchmarks for Urological Surgery in the UAE: Minimally Invasive, Maximum Results! https://ml-eu.globenewswire.com/media/be33dcd0-580b-4bd9-a5d5-78c0b62a0e6d/medium/dr-kamalesh-sets-new-benchmarks-for-urological-surgery-in-th.png https://healthheraldgrenada.com/article/915974094-edap-announces-corporate-name-change-to-focaltherics-to-reflect-exclusive-focus-on-high-growth-robotic-focal-therapy Health Herald Grenada en PressRelease 2026-05-29T11:30:00+00:00 EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy https://ml-eu.globenewswire.com/media/95e30a63-2d76-495a-a525-8e2d8b8f555c/small/focaltherics-blue-rgb-png.png https://healthheraldgrenada.com/article/915974469-at-asco-and-eha-2026-new-data-reinforce-the-pivotal-role-of-clonoseq-mrd-testing-across-hematology-clinical-practice-and-research Health Herald Grenada en PressRelease 2026-05-29T11:30:00+00:00 At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research https://ml.globenewswire.com/media/6c319974-0bac-45f1-83d9-ae9987dfdf44/small/adpt-new-logo-jpg.jpg https://healthheraldgrenada.com/article/915974512-aptose-biosciences-announces-update-on-anticipated-timing-of-closing-of-the-plan-of-arrangement-with-hanmi-pharmaceutical Health Herald Grenada en PressRelease 2026-05-29T11:30:00+00:00 Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical https://ml.globenewswire.com/media/3f4ab307-5947-4ef1-b5b5-c2c66933728a/small/aptose-biosciences-inc-logo.jpg https://healthheraldgrenada.com/article/915961395-mud-wtr-reviews-is-this-mushroom-coffee-alternative-worth-drinking Health Herald Grenada en PressRelease 2026-05-29T11:29:09+00:00 Mud Wtr Reviews: Is This Mushroom Coffee Alternative Worth Drinking? https://ml-eu.globenewswire.com/media/96918e5d-3103-4b6c-a01c-f9d0b335bf16/small/imagesf-png.png https://healthheraldgrenada.com/article/915961561-spectral-medical-announces-pma-submission-to-u-s-fda-for-pmx Health Herald Grenada en PressRelease 2026-05-29T11:00:00+00:00 Spectral Medical Announces PMA Submission to U.S. FDA for PMX https://ml.globenewswire.com/media/9516c02b-7f3b-41c0-bac1-a037af9a3240/small/new-spectral-logo-rgb-jpg.jpg https://healthheraldgrenada.com/article/915961576-agios-provides-update-on-phase-2b-trial-of-tebapivat-in-lower-risk-myelodysplastic-syndromes Health Herald Grenada en PressRelease 2026-05-29T11:00:00+00:00 Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://healthheraldgrenada.com/article/915961594-picard-medical-inc-issues-letter-to-shareholders Health Herald Grenada en PressRelease 2026-05-29T11:00:00+00:00 PICARD MEDICAL, INC. Issues Letter to Shareholders https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://healthheraldgrenada.com/article/915961605-seer-files-itc-complaint-against-nanomics Health Herald Grenada en PressRelease 2026-05-29T11:00:00+00:00 Seer Files ITC Complaint Against Nanomics https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://healthheraldgrenada.com/article/915961558-pharvaris-to-present-clinical-data-at-the-eaaci-annual-congress-2026 Health Herald Grenada en PressRelease 2026-05-29T10:50:00+00:00 Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026 https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://healthheraldgrenada.com/article/915935522-ent-allergy-associates-advances-strategic-expansion-with-new-facilities-and-care-innovations Health Herald Grenada en PressRelease 2026-05-29T08:00:00+00:00 ENT & Allergy Associates Advances Strategic Expansion with New Facilities and Care Innovations https://ml.globenewswire.com/media/NGJlNTNkNWMtMzJiMC00NTIzLWI3OTMtNmUxYjg5MjQ1MDI1LTExMDI1ODQtMjAyNi0wNS0yOS1lbg==/tiny/ENT-Allergy-Associates.png https://healthheraldgrenada.com/article/915912886-sequana-medical-announces-presentation-on-recompensation-of-decompensated-cirrhosis-following-alfapump-placement-at-easl-congress-2026 Health Herald Grenada en PressRelease 2026-05-29T05:00:00+00:00 Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026 https://ml-eu.globenewswire.com/media/b5ba012f-32c9-4567-bb3a-c01eb27aa4b0/small/sequana-rgb-300-png.png https://healthheraldgrenada.com/article/915882468-gumitide-gummies-under-investigation-examining-customer-complaints-ingredients-claims-and-serious-side-effects-risk Health Herald Grenada en PressRelease 2026-05-29T02:14:36+00:00 Gumitide Gummies Under Investigation: Examining Customer Complaints, Ingredients Claims and Serious Side Effects Risk https://zingfast.com/wp-content/uploads/2026/05/Gumitide-Gummies.jpg https://healthheraldgrenada.com/article/915829796-medirom-group-reports-q1-2026-results Health Herald Grenada en PressRelease 2026-05-28T22:43:13+00:00 MEDIROM Group Reports Q1 2026 Results https://ml.globenewswire.com/media/813811db-7d96-403a-a6d3-86af55b8315e/medium/reraku-salon.jpg https://healthheraldgrenada.com/article/915829706-new-research-from-ati-advisory-finds-i-snp-enrollment-associated-with-better-outcomes-for-long-term-care-residents Health Herald Grenada en PressRelease 2026-05-28T22:28:00+00:00 New Research from ATI Advisory Finds I-SNP Enrollment Associated with Better Outcomes for Long-Term Care Residents https://ml.globenewswire.com/media/f4f644ed-e5d8-4775-b6e9-5b9365a97f6b/small/ati-advisory-logo.png https://healthheraldgrenada.com/article/915829728-fortis-life-sciences-erweitert-sein-abnano-portfolio-um-die-erste-vhh-bibliothek-die-aus-peripheren-nat-rlichen-killerzellen-gewonnen-wurde-und-der Health Herald Grenada en PressRelease 2026-05-28T21:50:31+00:00 Fortis Life Sciences erweitert sein AbNano®-Portfolio um die erste VHH-Bibliothek, die aus peripheren natürlichen Killerzellen gewonnen wurde und der schnellen Antikörperentwicklung dient https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://healthheraldgrenada.com/article/915829730-fortis-life-sciences-enrichit-son-portefeuille-abnano-avec-la-premi-re-biblioth-que-vhh-d-riv-e-de-cellules-tueuses-naturelles-p-riph-riques-pour Health Herald Grenada en PressRelease 2026-05-28T21:50:31+00:00 Fortis Life Sciences enrichit son portefeuille AbNano® avec la première bibliothèque VHH dérivée de cellules tueuses naturelles périphériques pour accélérer la découverte d’anticorps https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://healthheraldgrenada.com/article/915811760-taurus-meds-trt-claims-evaluated-powerful-testosterone-replacement-therapy-taurus-charge-ed-medication Health Herald Grenada en PressRelease 2026-05-28T21:29:03+00:00 Taurus Meds TRT Claims Evaluated: Powerful Testosterone Replacement Therapy & Taurus Charge ED Medication https://zingfast.com/wp-content/uploads/2026/05/Taurus-Meds-TRT.jpg https://healthheraldgrenada.com/article/915811199-san-antonio-authentic-counseling-expands-veteran-mental-health-accessibility-efforts-in-military-city-usa Health Herald Grenada en PressRelease 2026-05-28T21:07:00+00:00 San Antonio Authentic Counseling Expands Veteran Mental Health Accessibility Efforts in Military City USA https://pressranger.s3.us-west-1.amazonaws.com/3328719/Military-member-in-therapy.jpg https://healthheraldgrenada.com/article/915811179-kane-biotech-announces-first-quarter-2026-financial-results Health Herald Grenada en PressRelease 2026-05-28T21:05:00+00:00 Kane Biotech Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/a2ad1d52-1d5a-425c-93de-45cc52c3784b/small/kane-logo-cropped-transbg-png.png https://healthheraldgrenada.com/article/915811147-allogene-therapeutics-announces-planned-ceo-succession Health Herald Grenada en PressRelease 2026-05-28T21:02:00+00:00 Allogene Therapeutics Announces Planned CEO Succession https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://healthheraldgrenada.com/article/915811091-caphra-families-feel-the-benefits-when-smokers-switch-away-from-cigarettes Health Herald Grenada en PressRelease 2026-05-28T21:00:00+00:00 CAPHRA: Families feel the benefits when smokers switch away from cigarettes https://ml.globenewswire.com/media/6dc95f2d-65fb-409f-aed4-9ebe55554004/small/picture1-png.png https://healthheraldgrenada.com/article/915811202-pelthos-therapeutics-to-participate-in-2026-jefferies-global-healthcare-conference Health Herald Grenada en PressRelease 2026-05-28T21:00:00+00:00 Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/7d71f2d0-a48f-4fe0-a49c-138de21bc0e1/small/pelthos-logo-rgb-png.png https://healthheraldgrenada.com/article/915811030-wegweisende-therapie-bei-fortgeschrittener-herzinsuffizienz-ergebnisse-der-klinischen-studie-biovat-hf-im-nejm-ver-ffentlicht Health Herald Grenada en PressRelease 2026-05-28T20:56:06+00:00 Wegweisende Therapie bei fortgeschrittener Herzinsuffizienz: Ergebnisse der klinischen Studie BIOVAT-HF im NEJM veröffentlicht https://ml-eu.globenewswire.com/media/3d3e4738-405b-4e38-80fc-a33e241c6d40/small/image1-png.png https://healthheraldgrenada.com/article/915811664-keeps-trt-claims-evaluated-clinician-prescribed-testosterone-replacement-therapy-medication-online Health Herald Grenada en PressRelease 2026-05-28T20:55:21+00:00 Keeps TRT Claims Evaluated: Clinician-Prescribed Testosterone Replacement Therapy Medication Online https://zingfast.com/wp-content/uploads/2026/05/Keeps-TRT.jpg https://healthheraldgrenada.com/article/915811087-intuitive-announces-new-chief-commercial-and-marketing-officer-taylor-patton Health Herald Grenada en PressRelease 2026-05-28T20:30:00+00:00 Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton https://ml.globenewswire.com/media/db89f2a9-76ed-4743-84d3-a7ac75605b6c/small/logo-jpg.jpg https://healthheraldgrenada.com/article/915811183-tarsus-to-participate-in-upcoming-investor-conferences Health Herald Grenada en PressRelease 2026-05-28T20:30:00+00:00 Tarsus to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://healthheraldgrenada.com/article/915811387-medline-inc-announces-closing-of-upsized-secondary-offering-of-class-a-common-stock Health Herald Grenada en PressRelease 2026-05-28T20:30:00+00:00 Medline Inc. announces closing of upsized secondary offering of Class A common stock https://ml.globenewswire.com/media/70e45830-32e3-4232-b15b-7e43c436de41/small/log-medline-1200-630-center-png.png https://healthheraldgrenada.com/article/915811526-tonix-pharmaceuticals-presented-retrospective-u-s-real-world-claims-analysis-of-opioid-use-in-patients-with-fibromyalgia-at-the-2026-american-society Health Herald Grenada en PressRelease 2026-05-28T20:30:00+00:00 Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://healthheraldgrenada.com/article/915811011-repairon-annonce-la-publication-dans-le-nejm-des-r-sultats-de-l-essai-clinique-biovat-hf-une-th-rapie-innovante-pour-l-insuffisance-cardiaque-avanc-e Health Herald Grenada en PressRelease 2026-05-28T20:28:18+00:00 Repairon annonce la publication dans le NEJM des résultats de l’essai clinique BIOVAT-HF, une thérapie innovante pour l’insuffisance cardiaque avancée https://ml-eu.globenewswire.com/media/3d3e4738-405b-4e38-80fc-a33e241c6d40/small/image1-png.png https://healthheraldgrenada.com/article/915811216-leading-independent-proxy-advisory-firm-glass-lewis-recommends-stockholders-vote-for-all-of-pacira-s-director-nominees Health Herald Grenada en PressRelease 2026-05-28T20:20:00+00:00 Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://healthheraldgrenada.com/article/915811134-cdt-equity-inc-announces-receipt-of-nasdaq-deficiency-letter Health Herald Grenada en PressRelease 2026-05-28T20:15:00+00:00 CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter https://ml.globenewswire.com/media/ZDViZjE3YjUtNmIwYS00ZDUzLWExMWMtMDhlNDE3ZmJlNGYyLTEyNzQxMDItMjAyNi0wNS0yOC1lbg==/tiny/CDT-Equity-Inc-.png https://healthheraldgrenada.com/article/915791862-lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events Health Herald Grenada en PressRelease 2026-05-28T20:05:00+00:00 LB Pharmaceuticals to Participate in Upcoming June Investor Events https://ml.globenewswire.com/media/90903161-520e-409f-b2ac-dd18677b4bb8/small/lb-pharma-logo-png.png https://healthheraldgrenada.com/article/915791893-assembly-biosciences-announces-upcoming-investor-conference-presentations Health Herald Grenada en PressRelease 2026-05-28T20:05:00+00:00 Assembly Biosciences Announces Upcoming Investor Conference Presentations https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png https://healthheraldgrenada.com/article/915791911-equillium-to-participate-in-the-2026-jefferies-global-healthcare-conference Health Herald Grenada en PressRelease 2026-05-28T20:05:00+00:00 Equillium to Participate in the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/14ce766d-e697-461f-a27c-c1ee49c0eeff/small/equillium-logo-360x180-jpg.jpg https://healthheraldgrenada.com/article/915791949-ryojbaba-rings-the-nasdaq-stock-market-opening-bell-celebrating-its-mission-to-fight-poverty-on-the-global-stage Health Herald Grenada en PressRelease 2026-05-28T20:05:00+00:00 rYojbaba Rings the Nasdaq Stock Market Opening Bell, Celebrating Its Mission to “Fight Poverty” on the Global Stage https://ml.globenewswire.com/media/ff09d595-7120-499c-bab7-ce17a99c8756/medium/ceo-ryoji-baba-at-the-nasdaq-marketsite-podium.jpg https://healthheraldgrenada.com/article/915791954-cg-oncology-to-present-at-upcoming-investor-conferences-in-june Health Herald Grenada en PressRelease 2026-05-28T20:05:00+00:00 CG Oncology to Present at Upcoming Investor Conferences in June https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://healthheraldgrenada.com/article/915792048-kailera-therapeutics-to-present-at-the-2026-jefferies-global-healthcare-conference Health Herald Grenada en PressRelease 2026-05-28T20:05:00+00:00 Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://healthheraldgrenada.com/article/915791947-apogee-therapeutics-to-participate-in-upcoming-june-conferences Health Herald Grenada en PressRelease 2026-05-28T20:01:00+00:00 Apogee Therapeutics to Participate in Upcoming June Conferences https://ml.globenewswire.com/media/c7ab4c17-2e41-4560-b2a2-70d0c23c8c8b/small/apogeelogo-png.png https://healthheraldgrenada.com/article/915791962-editas-medicine-announces-updated-presentation-time-for-upcoming-investor-conference Health Herald Grenada en PressRelease 2026-05-28T20:01:00+00:00 Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference https://ml.globenewswire.com/media/03686b66-5cbc-40b5-9dfa-be0e7858ac97/small/editas-logo-small-1-jpg.jpg https://healthheraldgrenada.com/article/915792001-opus-genetics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Herald Grenada en PressRelease 2026-05-28T20:01:00+00:00 Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://healthheraldgrenada.com/article/915792004-healthequity-reports-first-quarter-ended-april-30-2026-financial-results-raises-guidance Health Herald Grenada en PressRelease 2026-05-28T20:01:00+00:00 HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance https://ml.globenewswire.com/media/30a1510d-03b1-4356-b38d-e9f75f1ec797/small/healthequitylogo-purple-2020-jpg.jpg https://healthheraldgrenada.com/article/915792192-emergent-biosolutions-receives-64-5-million-contract-modification-for-bat-botulism-antitoxin-heptavalent-a-b-c-d-e-f-g-equine-to Health Herald Grenada en PressRelease 2026-05-28T20:01:00+00:00 Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://healthheraldgrenada.com/article/915792009-sharp-therapeutics-presents-new-preclinical-data-supporting-novel-small-molecule-therapeutic-approach-for-niemann-pick-disease-type-c Health Herald Grenada en PressRelease 2026-05-28T20:00:00+00:00 Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C https://ml.globenewswire.com/media/f8deb7d3-f5a2-425c-8037-f82505e23121/small/st-logo-png.png https://healthheraldgrenada.com/article/915792130-outlook-therapeutics-announces-pricing-of-5-0-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules Health Herald Grenada en PressRelease 2026-05-28T20:00:00+00:00 Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://healthheraldgrenada.com/article/915792422-regeneron-s-ebola-antibody-recommended-by-world-health-organization-for-investigational-use-in-response-to-current-bundibugyo-ebolavirus-outbreak Health Herald Grenada en PressRelease 2026-05-28T20:00:00+00:00 Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://healthheraldgrenada.com/article/915792410-parexel-to-present-real-world-oncology-research-and-launch-new-patient-focused-campaign-at-asco-2026 Health Herald Grenada en PressRelease 2026-05-28T19:59:00+00:00 Parexel to Present Real-World Oncology Research and Launch New Patient-Focused Campaign at ASCO 2026 https://ml.globenewswire.com/media/589079d7-3915-4935-a2ad-feaf67969b03/medium/from-insights-to-life.jpg https://healthheraldgrenada.com/article/915791817-sequana-medical-announces-results-of-annual-general-meeting-of-shareholders Health Herald Grenada en PressRelease 2026-05-28T19:00:00+00:00 Sequana Medical announces results of Annual General Meeting of Shareholders https://ml-eu.globenewswire.com/media/b5ba012f-32c9-4567-bb3a-c01eb27aa4b0/small/sequana-rgb-300-png.png https://healthheraldgrenada.com/article/915792021-aclarion-inc-comments-on-echo-lake-capital-s-letter-and-unsolicited-proposal Health Herald Grenada en PressRelease 2026-05-28T18:49:24+00:00 Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://healthheraldgrenada.com/article/915774912-hospital-bed-solutions-by-prosperity-health-releases-industry-report-on-rising-aging-in-place-demand-across-new-england Health Herald Grenada en PressRelease 2026-05-28T18:30:00+00:00 Hospital Bed Solutions by Prosperity Health Releases Industry Report on Rising Aging-in-Place Demand Across New England https://pressranger.s3.us-west-1.amazonaws.com/3315407/woman-resting-comfortably-in-adjustable-hospital-bed-during-recovery.jpg https://healthheraldgrenada.com/article/915774860-bay-area-lyme-foundation-raises-900-000-at-lymeaid-2026-presenting-inaugural-neil-l-spector-md-legacy-award-and-300-000-in-emerging-leader Health Herald Grenada en PressRelease 2026-05-28T18:00:00+00:00 Bay Area Lyme Foundation Raises $900,000 at LymeAid 2026, Presenting Inaugural Neil L. Spector, MD, Legacy Award and $300,000 in Emerging Leader Grants https://ml.globenewswire.com/media/f4848932-5b28-4afe-b058-06a405f5c90d/medium/bal-2026-emerging-leader-award-winners.jpg https://healthheraldgrenada.com/article/915774887-medx-holdings-medh-announces-landmark-submission-for-dea-registration-through-lazydaze-abq-llc-joining-an-elite-group-of-public-companies Health Herald Grenada en PressRelease 2026-05-28T17:34:23+00:00 Medx Holdings (MEDH) Announces Landmark Submission for DEA Registration Through Lazydaze ABQ LLC, Joining an Elite Group of Public Companies Pioneering Federal Medical Cannabis Access https://ml.globenewswire.com/media/995733cb-620f-4ea6-b204-8b5b5689df30/small/medx-logo-jpg.jpg https://healthheraldgrenada.com/article/915774877-new-study-clubhouse-model-improves-quality-of-life-for-people-with-serious-mental-illness Health Herald Grenada en PressRelease 2026-05-28T17:27:29+00:00 New Study: Clubhouse Model Improves Quality of Life for People with Serious Mental Illness https://ml.globenewswire.com/media/YThiOWY1MmUtZDViYi00NTE5LTg2OTktMjQwMWViZWRkODkyLTUwMDE2MzMwMS0yMDI2LTA1LTI4LWVu/tiny/Fountain-House.png https://healthheraldgrenada.com/article/915758708-tevogen-advances-strategic-acquisition-initiatives-with-potential-to-support-approximately-100-million-in-combined-annual-revenue Health Herald Grenada en PressRelease 2026-05-28T16:30:00+00:00 Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue https://ml.globenewswire.com/media/31e6e8f1-0984-4686-a852-d665eba4e5ad/medium/tevogen-advances-strategic-acquisition-initiatives-with-pote.png https://healthheraldgrenada.com/article/915758655-as-who-pushes-restrictions-world-vape-day-calls-for-harm-reduction Health Herald Grenada en PressRelease 2026-05-28T16:18:37+00:00 As WHO Pushes Restrictions, World Vape Day Calls for Harm Reduction https://ml.globenewswire.com/media/68ff40a3-11fb-4ebf-9a1f-d154f2e0718f/medium/world-vapers-alliance-celebrates-world-vape-day.png https://healthheraldgrenada.com/article/915758591-allsup-highlights-stroke-awareness-and-ssdi-eligibility-during-national-stroke-awareness-month Health Herald Grenada en PressRelease 2026-05-28T16:18:11+00:00 Allsup Highlights Stroke Awareness And SSDI Eligibility During National Stroke Awareness Month https://ml.globenewswire.com/media/ZWE3NWZkMmItYzEwYy00MzJhLTkxNjctMDA5OWMyZDc2ZTk0LTEwOTcwODEtMjAyNi0wNS0yOC1lbg==/tiny/Allsup.png https://healthheraldgrenada.com/article/915758478-new-research-reveals-covid-19-s-long-term-impact-on-kids Health Herald Grenada en PressRelease 2026-05-28T16:00:56+00:00 New research reveals COVID-19's long-term impact on kids https://ml.globenewswire.com/media/a1c64344-b8aa-4278-82d7-9b0c023a1dfa/small/cn-hrz-rgb-150ppi-lg-jpg.jpg https://healthheraldgrenada.com/article/915742193-valneva-to-participate-at-u-s-and-european-investor-conferences-in-june Health Herald Grenada en PressRelease 2026-05-28T15:45:00+00:00 Valneva to Participate at U.S. and European Investor Conferences in June https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/val-logo-4c-jpg.jpg https://healthheraldgrenada.com/article/915742205-valneva-annonce-sa-participation-des-conf-rences-investisseurs-aux-tats-unis-et-en-europe Health Herald Grenada en PressRelease 2026-05-28T15:45:00+00:00 Valneva annonce sa participation à des conférences investisseurs aux États-Unis et en Europe https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/ https://healthheraldgrenada.com/article/915742656-brepocitinib-interest-gains-momentum-in-idiopathic-inflammatory-myopathies-as-rheumatologists-signal-readiness-for-targeted-steroid-sparing-therapies Health Herald Grenada en PressRelease 2026-05-28T15:36:15+00:00 Brepocitinib Interest Gains Momentum in Idiopathic Inflammatory Myopathies as Rheumatologists Signal Readiness for Targeted, Steroid-Sparing Therapies https://ml.globenewswire.com/media/ZTQ2ZjQ4YzAtZWM2MS00N2VhLTg2MTQtNWFjOGZhZjhkZWMyLTUwMDE1MTQyOC0yMDI2LTA1LTI4LWVu/tiny/Spherix-Global-Insights.png https://healthheraldgrenada.com/article/915742247-clue-becomes-the-first-insurance-covered-period-and-menstrual-cycle-tracker-in-the-world Health Herald Grenada en PressRelease 2026-05-28T15:34:07+00:00 Clue Becomes the First Insurance-Covered Period and Menstrual Cycle Tracker in the World https://ml-eu.globenewswire.com/media/da6152d8-8d87-4228-b007-52eafec73444/small/clue-logo-2-png.png https://healthheraldgrenada.com/article/915742537-1m-donation-promises-to-increase-access-to-cardiovascular-disease-diagnosis-and-treatment Health Herald Grenada en PressRelease 2026-05-28T15:15:00+00:00 $1M donation promises to increase access to cardiovascular disease diagnosis and treatment https://ml.globenewswire.com/media/MGNjZmQ4NmMtNzM2Ni00YjkwLWE3ZmQtZjdjNWE1YjFlYjM2LTEyODY2OTYtMjAyNi0wNS0yOC1lbg==/tiny/Calgary-Health-Foundation.png https://healthheraldgrenada.com/article/915742319-h1-receives-40m-investment-in-round-led-by-cvs-health-ventures Health Herald Grenada en PressRelease 2026-05-28T15:00:00+00:00 H1 Receives $40M Investment in Round Led by CVS Health Ventures https://ml.globenewswire.com/media/e2c95cc0-4f49-43c6-981c-f59f00748b51/medium/h1s-mission-is-to-connect-the-world-to-the-right-doctor.PNG https://healthheraldgrenada.com/article/915742457-pemvidutide-demonstrates-significant-metabolic-improvements-in-patients-with-mash-in-new-48-week-impact-phase-2b-data-presented-at-easl-2026 Health Herald Grenada en PressRelease 2026-05-28T15:00:00+00:00 Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026 https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://healthheraldgrenada.com/article/915742521-radiomedix-to-present-at-snmmi-2026-and-mark-20-years-of-radiopharmaceutical-innovation Health Herald Grenada en PressRelease 2026-05-28T14:42:30+00:00 RadioMedix to Present at SNMMI 2026 and Mark 20 Years of Radiopharmaceutical Innovation https://ml.globenewswire.com/media/24205fa9-2ab0-4a06-ac44-f6e248fdd4bb/small/picture1-png.png